by Stacey Johnson | Nov 29, 2019
While this November has been dramatic on the weather front, it has been unremarkable as far as Movember goes. I am only n=1, but I haven’t noticed any unusual facial hair growing on male colleagues, friends and family. In fact, I think I’ve spotted only two...
by Farah Qaiser | Nov 20, 2019
Stem cells offer a lot of promise and potential when it comes to regeneration, but the field also faces a lot of hype and misinformation. To tackle this, the Royal Canadian Institute for Science (RCIScience) hosted a panel in October titled “Stem cells: the path to...
by Stacey Johnson | Nov 14, 2019
This cartoon from 1988, drawn by Riana Duncan for Punch, was included in a talk titled “In Search of the Lehman Sisters: Why Your Insights are Needed,” by Shari Graydon, Founder of Informed Opinions, at a “Women in Regenerative Medicine Luncheon” at the 2019 Till...
by David Kent | Nov 7, 2019
In October, I participated in a workshop hosted by Medicine by Design (MbD) in Toronto. The workshop was right up my alley – blood stem cells and clonal evolution – but I’ll spare the Signals readership the specific details.* Rather, today’s post focuses...
by Farah Qaiser | Oct 30, 2019
Earlier this month, over 8,900 individuals (including me!) headed to Houston to attend the 2019 American Society of Human Genetics’ (ASHG) Annual Meeting and learn more about cutting-edge research, science literacy and policy issues in the fields of genetics and...
by Tara Fernandez | Oct 24, 2019
In a dark corner of the nucleus, a mutation lurks, up to no good. It stealthily swaps a DNA base – an A to a T – gleefully awaiting the catastrophic consequences on the encoded protein. A brave CRISPR molecule enters the nucleus and armed with its...
by Tara Fernandez | Oct 17, 2019
RNA-based vaccines have been heralded as a new molecular weapon in the arsenal against cancer and infections. Five years ago, they were thrust into the spotlight following a $52 million investment by the Bill and Melinda Gates Foundation to CureVac, a...
by CCRM Australia | Oct 10, 2019
Dr. Chih Wei Teng is Chief Operating Officer for CCRM Australia and wrote this blog with colleagues Alex Barrington and Dr. Emma Gallaher. To subscribe to the CCRM Australia newsletter: Click here Regenerative medicine is a risky business. The decades-long development...
by Stacey Johnson | Oct 4, 2019
One of the speakers invited to the Current Trends in Biotherapeutics Workshop, hosted by the Clinical Translation Education Group (CTEG),* was Alexandre Le Bouthillier, co-founder of Imagia. This Montreal-based company is harnessing the power of artificial...
Comments